Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Collagen alpha-2(V) chain is a protein encoded by the COL5A2 gene in humans and is one of the alpha chains that forms type V collagen, a low-abundance fibrillar collagen found in nearly all connective tissues. Type V collagen is typically co-expressed and forms heterotrimers with type I collagen. It plays a critical regulatory role in collagen fibril assembly, specifically controlling fibril diameter and the incorporation of other collagens, thereby contributing to tissue strength and integrity. Mutations in the COL5A2 gene cause the classical type of Ehlers-Danlos syndrome, a heritable connective tissue disorder characterized by hyperextensible skin, abnormal scarring, and joint hypermobility. Although COL5A2 participates in extracellular matrix structure, it is not considered a classical therapeutic target such as a receptor or enzyme; rather, it is a structural gene relevant for genetic diagnostics and research into connective tissue pathology.
Not applicable (no direct-targeted drugs known)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Collagen alpha-2(V) chain (COL5A2).